Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04791787 · ClinicalTrials.gov registry record · NA
Effect of Ketogenic Diet on Glucose Metabolism and Energy Expenditure in Type 2 Diabetes
A NA study of Type 2 Diabetes and Glucose Metabolism Disorders (Including Diabetes Mellitus), sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 2
- Study locations
NCT04791787: Completed NA study of Type 2 Diabetes and Glucose Metabolism Disorders (Including Diabetes Mellitus), sponsored by The University of Texas Health Science Center at San Antonio.
NCT04791787 is a NA study of Type 2 Diabetes and Glucose Metabolism Disorders (Including Diabetes Mellitus) that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 35 participants, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04791787, a NA study of Type 2 Diabetes and Glucose Metabolism Disorders (Including Diabetes Mellitus), has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study team will examine the effect of a ketogenic diet alone and ketogenic diet supplemented with oral ketones on how the body of individuals with type 2 diabetes respond to insulin, regulates insulin secretion, food intake and energetic pathways and influences body fat distribution.
Primary Outcome
A change in FPG will be measured
Conditions Studied
Interventions
- OTHER Standard weight maintaining diet
- OTHER Weight maintaining isocaloric ketogenic diet
- DIETARY_SUPPLEMENT Beta-hydroxy butyrate
Study Locations (2)
Texas
- University Health Systems-Texas Diabetes Institute - San Antonio
- University of Texas Health Science Center at San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2020-11-25 |
| Est. Completion | 2023-04-25 |
| Phase | NA |
What the finished NCT04791787 record still lists
NCT04791787 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Standard weight maintaining diet is the first listed.
NCT04791787 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04791787 about?
NCT04791787 is a clinical study titled "Effect of Ketogenic Diet on Glucose Metabolism and Energy Expenditure in Type 2 Diabetes". The study team will examine the effect of a ketogenic diet alone and ketogenic diet supplemented with oral ketones on how the body of individuals with type 2 diabetes respond to insulin, regulates insulin secretion, food intake and energetic pathways and influences body fat distribution.
What is the current status of trial NCT04791787?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2020-11-25. Estimated completion is 2023-04-25.
What conditions does trial NCT04791787 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Glucose Metabolism Disorders (Including Diabetes Mellitus), Energy Supply; Deficiency.
What interventions are being tested in trial NCT04791787?
The interventions under investigation include: Standard weight maintaining diet (OTHER), Weight maintaining isocaloric ketogenic diet (OTHER), Beta-hydroxy butyrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04791787?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04791787 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04791787's enrollment target sits among peer trials
35 246th of 327 higher than 79 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI